| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 72,223 | 72,223 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| GS PRIMARY - INTERNATIONAL EQUITY | 4,126,350 | 4,126,350 |
| GS PRIMARY - FIXED INCOME | 31,736,545 | 31,736,545 |
| GS PRIMARY - REAL ESTATE | 854,863 | 854,863 |
| GS PRIMARY - FIXED INCOME - MANAGERS, LLC | 16,477,881 | 16,477,881 |
| GS DOMESTIC EQUITY - DONALD SMITH SVC | 1,646,200 | 1,646,200 |
| GS INTERNATIONAL EQUITY - ALTRINSIC | 0 | 0 |
| GS INTERNATIONAL EQUITY - PICTET | 12,014,129 | 12,014,129 |
| GS DOMESTIC EQUITY - DSM LARGE CAP | 12,740,798 | 12,740,798 |
| GS INTERNATIONAL EQUITY - WILLIAM BLAIR INT'L | 9,670,366 | 9,670,366 |
| GS DOMESTIC EQUITY - GANNETT WELSH KOTLER | 1,734,709 | 1,734,709 |
| GS DOMESTIC EQUITY - DIAMOND HILL LVC | 13,428,747 | 13,428,747 |
| GS INTERNATIONAL EQUITY - ARTISAN DYNAMIC | 10,585,404 | 10,585,404 |
| GS INTERNATIONAL EQUITY - SPRUCEGROVE | 8,563,699 | 8,563,699 |
| GS DOMESTIC EQUITY - BARON CAPITAL | 13,454,961 | 13,454,961 |
| GS ALTERNATIVE INVESTMENTS | 1,024,613 | 1,024,613 |
| GS PROTEGE PARTNERS | 5,633,274 | 5,633,274 |
| GS HEDGE FUNDS | 13,872,353 | 13,872,353 |
| GS AVENIR | 9,886,478 | 9,886,478 |
| GS ETF STRATEGY - DOM EQUITY | 2,041,965 | 2,041,965 |
| GS ETF STRATEGY - INTL EQUITY | 2,022,687 | 2,022,687 |
| GS ETF STRATEGY - FIXED INC. | 1,702,920 | 1,702,920 |
| GS PRIMARY - DOM EQUITY | 1,192,686 | 1,192,686 |
| GS CAUSEWAY - INTERNATIONAL EQUITY | 10,282,003 | 10,282,003 |
| ALDER BIOPHARMACEUTICALS | 19,753,600 | 19,753,600 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ACCIUM BIOSCIENCES, INC. | FMV | 250,000 | 250,000 |
| ACYLIN THERAPEUTICS, INC. | FMV | 659,255 | 659,255 |
| ALDER BIOPHARMACEUTICALS | FMV | 0 | 0 |
| RECEPTOS (FKA APOPTOS, INC.) | FMV | 0 | 0 |
| APPATTACH | FMV | 0 | 0 |
| CARDEAS PHARMA CORP. | FMV | 3,046,816 | 3,046,816 |
| CARDIAC INSIGHT | FMV | 369,349 | 369,349 |
| DECIDE.COM (AKA PRICEYETI) | FMV | 0 | 0 |
| ENERG2 | FMV | 4,216,176 | 4,216,176 |
| FIBROGEN | FMV | 43,700 | 43,700 |
| FLEXMINDER | FMV | 600,000 | 600,000 |
| GLOBEIMMUNE INC. | FMV | 112,113 | 112,113 |
| IKARIA | FMV | 104,589 | 104,589 |
| LUCENT MEDICAL SYSTEMS | FMV | 42,000 | 42,000 |
| LUMISANDS | FMV | 4,891 | 4,891 |
| MICROGREEN POLYMERS INC. | FMV | 4,594,100 | 4,594,100 |
| MIRADOR BIOMEDICAL INC. | FMV | 795,000 | 795,000 |
| GROOVE BIOPHARMA (FKA MIRINA CORP.) | FMV | 1,044,206 | 1,044,206 |
| MOBISANTE | FMV | 1,484,441 | 1,484,441 |
| MODUMETAL | FMV | 912,877 | 912,877 |
| NEUROGRAFIX | FMV | 50,000 | 50,000 |
| NLIGHT PHOTONICS | FMV | 163,972 | 163,972 |
| ONCOFACTOR CORP. | FMV | 428,400 | 428,400 |
| NIMBIC (FKA PHYSWARE INC.) | FMV | 75,000 | 75,000 |
| RESOLVE THERAPEUTICS INC. | FMV | 1,500,000 | 1,500,000 |
| PROTEMO (FKA SIGBY.COM) | FMV | 250,000 | 250,000 |
| SKYTAP (FKA ILLUMITA INC.) | FMV | 2,266,348 | 2,266,348 |
| TARGETED GROWTH | FMV | 0 | 0 |
| UPTAKE MEDICAL CORP. | FMV | 2,340,101 | 2,340,101 |
| VIRAL LOGIC SYSTEMS CORP. | FMV | 1,168,323 | 1,168,323 |
| ACCELERATOR III | FMV | 436,232 | 436,232 |
| ALLIANCE OF ANGELS SEED FUND | FMV | 133,509 | 133,509 |
| ARCH VENTURE FUND VI | FMV | 2,795,026 | 2,795,026 |
| ARCH VENTURE FUND VII | FMV | 1,863,829 | 1,863,829 |
| VOYAGER CAPITAL | FMV | 24,517 | 24,517 |
| SNUPI TECHNOLOGIES INC. | FMV | 1,511,178 | 1,511,178 |
| ANSWERDASH (FKA QAZZOW) | FMV | 876,828 | 876,828 |
| SHIPPABLE | FMV | 75,234 | 75,234 |
| JUNO THERAPEUTICS | FMV | 500,000 | 500,000 |
| FARADAY PHARMACEUTICALS | FMV | 500,000 | 500,000 |
| Category / Item | Cost / Other Basis | Accumulated Depreciation | Book Value | End of Year Fair Market Value |
|---|---|---|---|---|
| LEASEHOLD IMPROVEMENTS | 341,331 | 256,766 | 84,565 | 84,565 |
| EQUIPMENT | 354,198 | 332,671 | 21,527 | 21,527 |
| FURNITURE & FIXTURES | 172,938 | 156,360 | 16,578 | 16,578 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LEGAL FEES | 492,693 | 475,244 | 15,661 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| ACCRUED LICENSING FEES | 40,266,162 | 23,591,461 | 23,591,461 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INSURANCE | 44,510 | 31,157 | 17,134 | |
| BANK CHARGES | 2,450 | 1,736 | 0 | |
| OFFICE EQUIPMENT & COMMUNICATIONS | 45,720 | 32,005 | 19,891 | |
| REFERENCE MATERIALS | 49,652 | 36,191 | 21,437 | |
| OFFICE SUPPLIES | 20,151 | 14,104 | 9,077 | |
| RESEARCH EXPENSE | 51,224,509 | 51,224,509 | 0 | |
| VENTURE CENTER | 275,963 | 219,107 | 56,856 | |
| SPONSORSHIPS | 27,000 | 16,400 | 2,500 | |
| PENALTIES | 21 | 0 | 0 | |
| EQUITY PARTNERSHIPS | 0 | 409,680 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| SWAP INCOME FROM K-1 | 33,983 | ||
| PFIC INCOME FROM K-1 | 3,187 | ||
| ROYALTY & LICENSE | 73,433,245 | 73,433,245 | 73,433,245 |
| Description | Amount |
|---|---|
| UNREALIZED GAIN ON INVESTMENTS | 27,909,096 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| OTHER PROFESSIONAL FEES | 1,059,929 | 993,945 | 52,376 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXCISE TAXES | 230,000 | 0 | 0 | |
| PROPERTY TAXES | 2,879 | 2,879 | 0 | |
| FOREIGN TAXES | 0 | 79,953 | 0 | |
| OTHER TAXES | 691,664 | 691,595 | 0 |